Risedronate vs Raloxifene in Hormone Replacement Therapy Discontinuation

Summary

This is a multi-center, randomized, double-blind, double-dummy study designed to compare the effects of risedronate, raloxifene, and placebo on BMD, bone turnover markers, and other markers of anabolic activity in postmenopausal women who previously received HRT.

Timeline

Start

2004-06

Primary completion

—

Completion

2004-10

Drugs

Indications